Roche’s Vabysmo Could Nab Nearly One Third of Regeneron’s Eylea Patients
Roche’s intraocular injectable Vabysmo has made impressive gains since its approval in January, cranking up the heat on Regeneron’s Eylea. [...]
Advertisement
Roche’s intraocular injectable Vabysmo has made impressive gains since its approval in January, cranking up the heat on Regeneron’s Eylea. [...]
